Insights From Authors & Announcements
-
Aging | Are Menopause, Aging and Prostate Cancer Diseases?
PRESS RELEASE: Dr. Blagosklonny published a new research perspective in Aging’s Volume 15, Issue 2, entitled, “Are menopause, aging and prostate cancer diseases?”
-
Aging | Clearance of p16Ink4a+ Cells: Limited Effects on B-Cell Mass and Proliferation in Mice
PRESS RELEASE: A new research paper was published on the cover of Aging’s Volume 15, Issue 2, entitled, “Clearance of p16Ink4a-positive cells in a mouse transgenic model does not change β-cell mass and has limited effects on their proliferative capacity.” … continue reading
-
Aging | FBXC-58 Mediates Dietary Restriction Effects on Healthy Aging in C. Elegans
PRESS RELEASE: A new research paper was published in Aging’s Volume 15, Issue 1, entitled, “The innate immune signaling component FBXC-58 mediates dietary restriction effects on healthy aging in Caenorhabditis elegans.” … continue reading
-
Aging | Genetic Deficiency and Pharmacological Modulation of RORα Regulate Laser-Induced Choroidal Neovascularization
PRESS RELEASE: A new research paper was published in Aging’s Volume 15, Issue 1, entitled, “Genetic deficiency and pharmacological modulation of RORα regulate laser-induced choroidal neovascularization.” … continue reading
Aging: Volume 15, Issue 2
-
Clearance of p16Ink4a-positive cells in a mouse transgenic model does not change β-cell mass and has limited effects on their proliferative capacity
Type 2 diabetes is partly characterized by decreased β-cell mass and function which have been linked to cellular senescence. Despite a low basal proliferative rate of adult β-cells, they can respond to growth stimuli, but this proliferative capacity decreases with age and correlates with increased expression of senescence effector, p16Ink4a.
Aging News & Blogs
ABOUT AGING-US.NET
Aging-US.net features interviews and testimonials from the distinguished network of authors who continue to publish their research with Aging (Aging-US)—a twice-monthly, traditional, peer-reviewed journal with open access, covering all areas of research on aging, including age-related diseases, such as cancer.
The journal aims to promote treatment of age-related diseases by slowing down aging, validation of anti-aging drugs by treating age-related diseases and prevention of cancer by inhibiting aging. Cancer and COVID-19 are age-related diseases.
Impact Journals, the publisher of Aging (Aging-US), meets the standards of the Wellcome Trust Publisher Requirements and was included in the Wellcome Trust List of Compliant Publishers. Read about our rigorous Scientific Integrity Process.
To learn more, please visit Aging-US.com and connect with us:
Facebook | Twitter | LinkedIn | YouTube | Instagram | Pinterest | SoundCloud
